Search
for
Sort by
Research 391–420 of 1000+
- FRI220 Primary Bilateral Macronodular Adrenal Hyperplasia: A Rare Cause Of Cushing Syndrome
- Postmenopausal Alopecia due to Ovarian Hyperandrogenemia Treated with Bilateral Salpingo-oophorectomy
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- Androgen Receptor Antagonists (Antiandrogens) Structure-Activity Relationships
- Relationship Between Androgen Levels and Blood Pressure in Young Women With Polycystic Ovary Syndrome
- Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- The importance of adequate serum ferritin levels during oral cyproterone acetate and ethinyl oestradiol treatment of diffuse androgen-dependent alopecia in women
- Lichen Planopilaris and Frontal Fibrosing Alopecia as Model Epithelial Stem Cell Diseases
- Clinical and biological impact of the exposome on the skin
- Oestrogen functions in skin and skin appendages
- Recent advances in the molecular mechanisms determining tissue sensitivity to glucocorticoids: novel mutations, circadian rhythm and ligand-induced repression of the human glucocorticoid receptor
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Chrousos syndrome: from molecular pathogenesis to therapeutic management
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- The effect of weight loss and treatment with metformin on serum vaspin levels in women with polycystic ovary syndrome
- Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam’s criteria and women whose only clinical signs are oligo/anovulation or hirsutism
- The Efficacy of 24-Month Metformin for Improving Menses, Hormones, and Metabolic Profiles in Polycystic Ovary Syndrome
- A missing piece: the spiny mouse and the puzzle of menstruating species
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Acne severity and the Global Acne Grading System in polycystic ovary syndrome
- Getting under the skin of hair aging: the impact of the hair follicle environment
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Do Different Diagnostic Criteria Impact Polycystic Ovary Syndrome Diagnosis for Adolescents?
- Measurement of steroid hormones by liquid chromatography-tandem mass spectrometry with small amounts of hair
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- EVALUATION OF ASSOCIATION OF ANTHROPOMETRIC INDICES WITH STRESS RESPONSE IN PCOS POPULATION